Jun 11, 2015 7:00 am EDT NeoGenomics Launches Twelve NeoLAB™ "Liquid Biopsy" Tests for Hematologic Diseases
Apr 28, 2015 7:00 am EDT NeoGenomics Reports 27% Revenue Growth Driven by Strong Volume Gains and PathLogic Acquisition
Feb 24, 2015 7:00 am EST NeoGenomics Reports Record Revenue of $25.0 Million, Adjusted EBITDA of $2.8 MM and Net Income of $0.02 per Share for the Fourth Quarter 2014
Feb 4, 2015 6:00 am EST NeoGenomics Schedules its Q4 2014 and Full Year 2014 Earnings Release for February 24, 2015
Jan 22, 2015 5:55 pm EST NeoGenomics Raises Revenue Guidance to $25 Million and EPS Guidance to $0.01 - $0.02 per share for Quarter 4, 2014
